When was Metabolon founded?

Metabolon was founded in 2000 and raised its 1st funding round 3 years after it was founded.

Where is Metabolon located?

Metabolon is headquartered in Morrisville, United States. It is registered at Morrisville, North Carolina.

How many employees does Metabolon have?

As of Mar 31, 2026, the latest employee count at Metabolon is 199.

Is Metabolon a funded company?

Metabolon is a funded company, having raised a total of $166M across 20 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Mar 2003.

When was the latest funding round of Metabolon?

Metabolon's latest funding was a $***** Grant (prize money) round on Feb 06, 2025, with participation from 1 investor.

Where does Metabolon rank among its competitors?

Metabolon ranks 4th amongst 90 active competitors, of which 30 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Lexicon Pharmaceuticals, which secured $55.7M in Feb, 2026.

Who are the top competitors of Metabolon?

Metabolon's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics. Among them, Lexicon Pharmaceuticals secured the most recent funding round in February, 2026.

Metabolon - 2026 Company Profile, Team, Funding & Competitors

Metabolon is a series H company based in Morrisville (United States), founded in 2000 by John Ryals. It operates as a Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine. Metabolon has raised $166M in funding from investors like Sevin Rosen, Fletcher Spaght and Fulcrum Financial Group. The company has 90 active competitors, including 30 funded and 17 that have exited. Its top competitors include companies like Alector, Lexicon Pharmaceuticals and Maze Therapeutics.

Company Details

Provider of solutions for biomarker discovery, diagnostic tests, and personalized medicine. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. It also offers Quantose IR, a lab test for prediabetes assessment and treatment, and Meta IMD, a CLIA assay for inborn errors of metabolism. The company is also developing metabolomics-based clinical diagnostic tests that may improve the early detection of obesity-related metabolic diseases.

Website: metabolon.com
Social
Registered Address: Morrisville, North Carolina

Key Metrics

Founded Year

2000

Location

Morrisville, United States

Stage

Series H

Total Funding

$166M in 20 rounds

Latest Funding Round

Grant (prize money), Feb 06, 2025, $*****

Investors

Sevin Rosen & 18 more

Ranked

4^th among 90 active competitors

Employee Count

199 as on Mar 31, 2026

Investment & Acquisitions

Metabolomic Discoveries & 2 more

Similar Companies

Alector & 117 more

View Metabolon's full profile

Metabolon is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Metabolon, Inc. CIN: 43518046 , United States, Active	Dec 31, 1999	-	122 (As on Dec 31, 2024)	-
Metabolon, Inc. CIN: 20171291338 , United States, Active	Apr 17, 2017	-	-	-

Metabolon has raised a total funding of $166M over 20 rounds. Its first funding round was on Mar 2003. Its latest funding round was a Grant (prize money) round on Feb 06, 2025 for $*****. 1 investor participated in its latest round. Metabolon has 19 institutional investors.

Here is the list of recent funding rounds of Metabolon:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 06, 2025	6039675	Grant (prize money)	6754437	9077603	4854869	9951744
Dec 31, 2024	5523100	Series H	8212730	1188172	7561458	7986388
May 01, 2024	4934779	Grant (prize money)	6224584	5432954	3285601	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Metabolon's funding rounds and investors

The founders of Metabolon is John Ryals.

Here are the details of Metabolon's key team members:

John Ryals: Founder, Chairman Emeritus and Board Member of Metabolon.

Metabolon's Board of Directors

Metabolon's board has 30 active members. John Fletcher, John Oxaal, Scott Barry, David Pierson, Edward L. Erickson, Robert Cascella, Rudy Howard, S. Todd Lynch, Carol A. Marino, Edward L Erickson, John A Ryals, Stephen Furlong, Jefferson B. Clark, Rohan F. Hastie, Guy Fish, R. Scott Barry, John A. Ryals, Todd Schermerhorn, Jan Lundberg, Christopher Kersey, Santo J. Costa, C. Thomas Caskey, R. John Fletcher, C Thomas Caskey, B. Jefferson Clark, Gerald M. Haines II, Edward L. Erikson, Jefferson B Clark, Rohan Hastie and John Kurtzweil are independent board members.

Here is the list of Metabolon's board of directors:

Name	Type	Representing	Status	Duration
John Fletcher	Independent board member	-	Current	9y 7m
bkiusbx	Independent board member	-	Current	8y 2m
dyhrsff	Independent board member	-	Current	9y 8m
dwneaus	Independent board member	-	Current	2y 3m
obwuxnc	Independent board member	-	Current	3y 8m
o{h{hcu	Independent board member	-	Current	4y 3m
vevqoce	Independent board member	-	Current	2y 8m
pknbhgz	Independent board member	-	Current	5y 6m
thmbfcq	Independent board member	-	Current	2y 8m
xdbytlh	Independent board member	-	Current	6y 4m
ddigy{v	Independent board member	-	Current	2y 9m
ggtvizi	Independent board member	-	Current	3y 1m
dadlrjt	Independent board member	-	Current	5y 1m
cdlfinp	Independent board member	-	Current	1y 3m
jxekqut	Independent board member	-	Current	5y 7m
ovzdhcu	Independent board member	-	Current	7y 2m
{soy{zv	Independent board member	-	Current	5y 5m
ftkalpq	Independent board member	-	Current	1y 9m
q{lblqx	Independent board member	-	Current	7y 3m
psbtozm	Independent board member	-	Current	1y 6m
umhdjce	Independent board member	-	Current	3y 6m
yhrztzt	Independent board member	-	Current	1y 1m
tzsavby	Independent board member	-	Current	6y 1m
qhmiquo	Independent board member	-	Current	4y 8m
qramyi{	Independent board member	-	Current	5y 6m
hcoqork	Independent board member	-	Current	5y 8m
mxhrvda	Independent board member	-	Current	7y 2m
mqjfsat	Independent board member	-	Current	3y 8m
ndvqqki	Independent board member	-	Current	1y 7m
ezlgnnd	Independent board member	-	Current	7y 2m

View details of Metabolon's Founder profiles and Board Members

Metabolon's employee count trend

Metabolon has 199 employees as of Mar 26. Here is Metabolon's employee count trend over the years:

Uncover Metabolon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Metabolon include Alector, Lexicon Pharmaceuticals and Maze Therapeutics. Here is the list of Top 10 competitors of Metabolon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alector 2013, San Francisco (United States), Public	Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders	$215M	AbbVie, The Dementia Discovery Fund & 20 others	73/100
2nd	Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public	Developer of small molecule drugs for diffrent health diseases	-	New Enterprise Associates, Bay City Capital ... & 3 others	68/100
3rd	Maze Therapeutics 2018, Redwood City (United States), Public	Developer of genetic bio-markers in neurological, metabolic, and renal diseases	$496M	Deep Track Capital, Frazier Life Sciences ... & 21 others	66/100
4th	Metabolon 2000, Morrisville (United States), Series H	Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine	$166M	Camden Partners, Innovatus Capital Partners ... & 17 others	66/100
5th	Tango Therapeutics 2017, Cambridge (United States), Public	Developer of drugs for the treatment of cancer	$165M	Boxer Capital, Casdin Capital & 7 others	62/100
6th	Seer 2017, San Francisco (United States), Public	Developer of proteomics platform for early detection of cancer and neurological diseases	$128M	aMoon, Fidelity Investments & 15 others	61/100
7th	Wobble Genomics 2020, Edinburgh (United Kingdom), Series A	Provider of a platform for discovery of nucleic acid biomarkers	$12.5M	Mercia, Eos Advisory & 35 others	61/100
8th	Oxford Biodynamics 2007, Oxford (United Kingdom), Public	Developer of personalized diagnostics by identifying biomarkers through epigenetics	$11M	Armistice Capital, Oxford University Innovation ... & 1 others	57/100
9th	Denovo Biopharma 2013, San Diego (United States), Series D	Developer of genomic biomarker discovery platform	$172M	Guangzhou Yuexiu Industrial Investment Fund Management, CICC ... & 12 others	56/100
10th	Immunovia 2007, Lund (Sweden), Public	Developer of protein diagnostics devices for the early detection of cancer	-	Smile Incubator, Almi Invest & 2 others	53/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Metabolon's competitors? Click here to see the top ones

Metabolon has acquired 3 companies including Metabolomic Discoveries, Lipomics and Lipomics. Metabolon has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 05, 2017	Acquisition	Metabolomic Discoveries	2009	Potsdam (Germany)
Aug 01, 2012	Acquisition	Lipomics	2000	Sacramento (United States)
Sep 17, 2008	Acquisition	Lipomics	2000	Sacramento (United States)